Luke Judge, MD, PhD
Associate Professor
Pediatrics
School of Medicine

415-734-2860

Dr. Judge is a physician-scientist with extensive experience with mouse and human models of genetic disease. His current research utilizes induced pluripotent stem cells (iPSC) and gene editing to model disease and develop therapies. His primary interests focus on therapeutic gene editing for dominant neurologic disorders.

Show full bio (90 words) Hide full bio

He is funded by the NIH and Charcot-Marie-Tooth Association to evaluate therapeutic gene editing strategies in human and murine models of genetic neuropathy and published the first study of a gene editing approach for axonal neuropathy (Feliciano et al, 2021). Dr. Judge is an Affiliate Investigator in the Gladstone Institute of Data Science and Biotechnology as well as a practicing neonatologist at UCSF Benioff Children’s Hospital. He is an active mentor in both the clinical and laboratory realms and directs the fellowship program in Neonatal-Perinatal medicine.

Education & Training

Show all (6) Hide

  • Diversity, Equity, and Inclusion Champion Training University of California 2019
  • Fellowship Neonatal-Perinatal Medicine University of California, San Francisco 2014
  • Residency Pediatrics University of California, San Francisco 2011
  • M.D. Medicine University of Washington 2008
  • Ph.D. Molecular and Cellular Biology University of Washington 2006
  • B.A. Chemistry Pomona College 1997

Grants and Projects

Show all (1) Hide

Publications (27)

Top publication keywords:
Induced Pluripotent Stem CellsPolymerase Chain ReactionLongevityDystrophinUtrophinClustered Regularly Interspaced Short Palindromic RepeatsGene EditingDNAMRE11 Homologue ProteinChromosome InversionMuscular Dystrophy, AnimalDependovirusMuscle, SkeletalCRISPR-Cas SystemsMuscular Dystrophy, Duchenne

Show all (22 more) Hide